Filing Flows › Volitionrx (VNRX) › Q4 2024
Volitionrx (VNRX) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 31, 2025
Volitionrx (VNRX) reported revenue of $192K for the fourth quarter 2024 (Q4 2024), -21% from a year earlier and -60% from the quarter before.
Volitionrx, Q4 2024: revenue $192K (-21% year over year), net loss $5.9M, operating cash flow −$5.4M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $192K | -60% | -21% |
| Operating profit | −$5.8M | — | — |
| Net earnings | −$5.9M | — | — |
| Operating cash flow | −$5.4M | — | — |
What changed
Revenue was $192K in Q4 2024, down 21% year over year and down 60% from the previous quarter.
Operating costs exceeded revenue by $5.8M, an operating margin of -3016.5%. Total costs fell 34% while revenue fell 21%. The quarter ended with a net loss of $5.9M, narrower than the previous quarter's $5.9M loss. Minority interests bore $64K of it: to shareholders the quarter was a loss of $5.8M.
Operating cash flow was −$5.4M. Non-cash charges added back $296K of depreciation and amortization and $326K of share-based compensation. Capital expenditures of $73K exceeded it, leaving free cash flow of −$5.5M.
Questions
What was Volitionrx's revenue in the fourth quarter 2024?
Volitionrx (VNRX) reported revenue of $192K for the fourth quarter 2024 (Q4 2024), -21% from a year earlier and -60% from the quarter before.
Source: Volitionrx 10-K on SEC EDGAR.